Georgina Arrambide
@GeoArrambide
Followers
844
Following
3K
Media
157
Statuses
1K
Neurologist, specialist in multiple sclerosis and related disorders
Barcelona, Spain
Joined October 2021
RT @cemcat_em: ⏰ Only 2 hours to go!.🧠 Real-life experience with NMOSD treatments. 🗓️Today | 16:00–17:00 (CEST).🔗 Check your email for acce….
0
2
0
RT @cemcat_em: 🙌 Thanks for joining today’s #CCEMPED session on MOGAD treatment in adults and children, with Prof. Yael Hacohen and Dr. Mar….
0
3
0
RT @ECTRIMS: What is spinal cord reserve? How can #MS progression be monitored using spinal cord imaging? At #ECTRIMS2025 in September, Dr.….
0
5
0
RT @ECTRIMS: 🧪 #Biomarkers is an exciting and fast-evolving area in MS research. What's new?.🎧Tune in to our latest #podcast with Charlotte….
0
1
0
RT @cemcat_em: 🙏 Gràcies a totes les persones que vau participar a la sessió sobre Fatiga i Esclerosi Múltiple!. 🗓️ La pròxima Sessió Infor….
0
1
0
Great and intensive annual MEDEN meeting in Lyon. @marignierro @SaraMariottoMD @RosaCortese5 @cobo_calvo @AYSEALT51949427 @EliaSechi @silvia06 @VukusicSandra @KerstinHellwig @GeoArrambide and many more.
3
3
22
RT @cemcat_em: 🧠 MOGAD o NMO: ¿dónde está el límite clínico? ¿Tiene sentido mantener la NMO seronegativa en los nuevos criterios? ¿Gestiona….
0
2
0
RT @JAMANeuro: Author Manuel Comabella discusses Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome wit….
0
5
0
RT @cemcat_em: Nova Sessió Informativa | Embaràs i Esclerosi Múltiple: què cal saber? - Dimecres, 11 de juny | 17:….
0
1
0
RT @JAMANeuro: Key biomarkers identified in individuals with radiologically isolated syndrome are associated with the development of multip….
0
15
0
What's New meeting, Madrid. Discussing the advantages and practicalities of the 2024 McDonald criteria and how to define progression in MS. @XMontalban @CarmenTur1 @cemcat_em @C_OrejaGuevara @SaraLlufriu and many more.
0
2
10
MEXCTRIMS XII Natuonal Congress: different topics covered including special populations; awards given to the best poster presentations, photo of 20/40 @INNNMVS demyelinating diseases fellows, and a Oaxacan night to conclude the day. @josefloresunc @irenetrefrenk and many more.
0
0
10
XII MEXCTRIMS National Congress: presentation of national guidelines for MS (@irenetrefrenk and others), moving homage to Giancarlo Comi, and review of the 2024 McDonald criteria by Prof. Hartung (overall), L. Leocani (visual pathway), MRI (@DanOntaneda) and CSF (@GeoArrambide).
0
2
18
RT @TheSumairaFDN: We're thrilled to co-sponsor the ECTRIMS-MEDEN Fellowship to further advance the understanding & research of #NMOSD & #M….
0
2
0
Annual meeting of the German Society for CSF Diagnostics and Neurochemistry, Graz. Topics: biomarkers in MS diagnosis, CH3L1, a great talk about neuropathology of AIE and demyelinating diseases by Romana Höftberger, and other diseases. @mcomabellalopez @GeoArrambide @cemcat_em
0
0
13
RT @RachelHorne19: Just one month to go!.Applications for the #RHPrize close on Tuesday June 10. This year’s $40,000 award honours an early….
0
8
0
RT @SCatalanaNeuro: 🛎️🛎️🛎️Per finalitzar la jornada d’avui no us perdeu la magnífica ponència del Dr. @XMontalban sobre “el diagnòstic biol….
0
4
0
RT @SCatalanaNeuro: Excel·lents presentacions dels grups de cognició, cefalees i esclerosi múltiple a la jornada d’ahir al matí de la #XXIX….
0
3
0
RT @MarTintore: Controvèrsies sobre els nous criteris diagnòstics #esclerosimultiple. Interessant debat entre la Dra @GeoArrambide i el Dr….
0
2
0